Cargando…
Recent improvements in the development of A(2B) adenosine receptor agonists
Adenosine is known to exert most of its physiological functions by acting as local modulator at four receptor subtypes named A(1), A(2A), A(2B) and A(3) (ARs). Principally as a result of the difficulty in identifying potent and selective agonists, the A(2B) AR is the least extensively characterised...
Autores principales: | Baraldi, Pier Giovanni, Tabrizi, Mojgan Aghazadeh, Fruttarolo, Francesca, Romagnoli, Romeo, Preti, Delia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583210/ https://www.ncbi.nlm.nih.gov/pubmed/18443746 http://dx.doi.org/10.1007/s11302-008-9097-z |
Ejemplares similares
-
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole
por: Romagnoli, Romeo, et al.
Publicado: (2016) -
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors
por: Gessi, Stefania, et al.
Publicado: (2006) -
Pharmacology of Adenosine Receptors: Recent Advancements
por: Vincenzi, Fabrizio, et al.
Publicado: (2023) -
Discovery and
Structure–Activity Relationship
Studies of Novel Adenosine A(1) Receptor-Selective Agonists
por: Preti, Barbara, et al.
Publicado: (2022) -
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A(3) adenosine receptor
por: Merighi, Stefania, et al.
Publicado: (2006)